Pavel Sokolovsky

clinical trials

to your health · Aug 2026

Intelligence is not the bottleneck.

“no matter how “intelligent” AI becomes, intelligence is often not the main bottleneck to things changing in the real world.” Ruxandra Bio argues that in medicine the grind of clinical trials, data access, and governance shape what actually gets built and approved, even if models keep improving. ~ learn more

under the microscope · Jan 2026

The power of surrogate endpoints.

“Surrogate endpoints: measurable intermediate biological signals that reliably predict clinical benefit, such as biomarkers or imaging readouts.” By utilizing these proxies, clinical trials can be significantly expedited, decreasing costs and increasing efficiency in drug development. ~ learn more

tech, startups, internet · Sep 2025

AI needs clinical trials.

“Harvard Business School professor Karim Lakhani shares groundbreaking research on AI's impact in the workplace through rigorous "clinical trials" at major organizations like BCG and Procter & Gamble. These studies reveal how AI fundamentally transforms work by lowering the cost of expertise—enabling average performers to reach 95th percentile levels and giving individuals access to cross-disciplinary knowledge previously requiring entire teams.” ~ learn more

under the microscope · Mar 2020

More than 80 clinical trials launch to test coronavirus treatments

I find it interesting for two reasons. 1) The World Health Organization is getting involved to set standards for studies and promote good design like control groups and randomization. 2) Traditional Chinese medicine is being tested, which I appreciate because while it’s silly to blindly accept homeopathic treatments it’s just as silly to not offer them a fair trial. | learn more

under the microscope · Jun 2019

FDA warns that fecal transplant is linked to a patient’s death

This is a real setback in FMT research. It highlights a need for better screening (like we do with blood). “The agency said two patients received donated stool that had not been screened for drug-resistant germs, leading it to halt clinical trials until researchers prove proper testing procedures are in place.” | learn more